Please login to the form below

kidney disease

This page shows the latest kidney disease news and features for those working in and with pharma, biotech and healthcare.

Astellas files new application for expanded use of roxadustat in Japan

Astellas has set its sights on extending the use of roxadustat into Japan, for the treatment of anaemia associated with chronic kidney disease (CKD) in non-dialysis patients. . ... The standard treatment used to treat anaemia in people with chronic

Latest news

Alnylam’s third RNAi drug clears phase 3 trial in rare kidney disease

If left untreated, PH1 can lead to end-stage renal disease and patients can sometimes need dialysis and/or a transplant. ... type 2 form (PH2) of the disease, which is caused by a different enzyme deficiency.
World Diabetes Day 2019

With close to 700 million people predicted to develop type 2 diabetes by 2045, we need to act now to address pre-diabetes and help prevent a disease that can cause ... Diabetes is a chronic condition, and is a leading cause of blindness, lower-limb
Evotec and Vifor announce joint venture for kidney disease treatments

of kidney disease. ... The discovery of novel nephrology therapeutics will be aided by analysis of clinical data provided by Evotec from the UK kidney biobank NURTuRE.
Alexion eyes Soliris combo with $930m deal to buy Achillion

paroxysmal nocturnal haemoglobinuria (PNH), a rare disease whose treatment is currently dominated by Alexion’s blockbuster complement C5 inhibitor Soliris (eculizumab). ... Achillion is developing its Factor D inhibitors for not only PNH but also C3
J&J’s Invokana gets lifeline with new kidney disease approval

Based on the results of the CREDENCE trial, Invokana (canagliflozin) has become the only drug in the SGLT2 inhibitor class to be approved for treating diabetic kidney disease (DKD), and to ... in patients with type 2 diabetes who are at risk of

More from news
Approximately 20 fully matching, plus 137 partially matching documents found.

Latest Intelligence

Case study: What we're made of

If we don’t drink enough water, it can lead to headaches, constipation, tiredness and more serious problems, such as urinary infections and kidney disease. ... This could be a side effect of a condition such as stroke, motor neurone disease, multiple
25 Women Leaders in UK Healthcare

The firm has just signed a long-term collaboration with AZ for the discovery of new drugs for chronic kidney disease and idiopathic pulmonary fibrosis (IPF). ... disease and applying machine learning, artificial intelligence and collapsing analysis to
Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

of JAK proteins is an established method of controlling the symptoms of this disease. ... The sales forecast for Zolgensma is $2.09bn. Roxadustat, from AstraZeneca, FibroGen and Astellas, targets anaemia in chronic kidney disease (CKD).
China: AstraZeneca’s new engine for growth and innovation

FibroGen in China for patients with anaemia in chronic kidney disease. ... AstraZeneca’s goal is to realise complete disease management, covering prevention, screening, diagnosis, treatment and follow- up.
The invisible army

Studies with COPD and chronic kidney disease patients indicate that carers can have a positive influence on patient adherence to medication and healthy behaviours, thus driving positive outcomes in the process.

More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest appointments

Sanifit appoints Alexander Gold chief medical officer

Alex arrives here with first class operational and clinical development expertise in novel drug therapies, targeting cardiovascular and metabolic disease and kidney disease amongst others.
Spectrum appoints chief medical officer

of iron deficiency anaemia in adult patients with chronic kidney disease.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Its Know Your Numbers week

One in 4 adults in the UK has high blood pressure so the risk of developing heart disease, heart attacks, strokes, kidney disease and vascular dementia are very real. ... Lack of exercise. Being overweight. Chronic Kidney Disease. Regularly drinking
What are you doing, Dave?

parents. Google's DeepMind is exploring the use of AI in managing head and neck cancer, acute kidney injury, and detection of eye disease. ... The IBM Watson supercomputer is also being used to help manage cancer, as well as analysing data on genes,
Lighthouse Medical Communications US makes the list of finalists for the 2018 PM360 Trailblalzer Awards

This exciting news is a true testament to the American Kidney Fund’s commitment to improving the lives of patients with chronic kidney disease. ACT on Anemia was one of a ... ACT on Anemia - Anemia in Chronic Kidney Disease, is a multi-channel
Making good practice common practice in rare disease

However, fatigue scores can’t be explained purely by disease activity and depression. ... 2015 - 88% of people with early-stage autosomal dominant polycystic kidney disease (ADPKD), reported physical symptoms including pain and general malaise.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Senior Medical Writer, MedComms Agency: Salary TBC

Experienced medical editor: Competitive salary and bonus scheme

Account director: Competitive salary and bonus scheme

Account Director, Healthcare Communications: Salary TBC

Account Manager: £Competitive Salary

Senior External Communications Lead: £Competitive Salary

Account Manager (PR): Great Benefits

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Digital Associate Director - Medcomms: £65000 - £80000 per annum

Account Director: £Competitive Salary

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Publications director: Competitive salary and bonus scheme

Account Director, Medical Education: Salary TBC

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Scientific Director: £60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more

Subscribe to our email news alerts

PMHub

Add my company

Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’: Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019: OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...